TRI-MIX 30/1/20 Injectable Recalled for Lack of Sterility Assurance
Carolina Infusion is recalling TRI-MIX 30/1/20 Injectable vials due to lack of assurance of sterility. The recall affects multiple lots distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with lack of sterility assurance on an injectable product. This is a risk-of-harm product where injury has not yet been reported. No illnesses or adverse events have been reported, placing this in the High category per the rubric.
Plain-English summary
Carolina Infusion LLC is recalling TRI-MIX 30/1/20 Injectable (5 mL vials), a prescription medication distributed nationwide in the United States.
The recall was issued due to lack of assurance of sterility. Injectable medications must meet strict sterility standards to prevent microbial contamination. The manufacturer cannot verify that this product meets these required standards.
The recall affects seven vials across multiple lots with beyond-use dates ranging from August 2022 to October 2022. Affected lots are: 06272022@6 (BUD 08/26/2022), 07212022@3 (BUD 09/19/2022), 07292022@11 (BUD 09/27/2022), 08052022@7 (BUD 10/04/2022), 08102022@5 (BUD 10/09/2022), 08122022@14 (BUD 10/11/2022), and 08172022@7 (BUD 10/16/2022).
Healthcare providers and patients who may have this product should contact their healthcare provider. No illnesses or adverse events have been reported in connection with this recall to date.
The recalled product
- Product
- TRI-MIX 30/1/20 Injectable, 5 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.
- Manufacturer
- Carolina Infusion
- Category
- Drug — Compounded Injectable
- Hazard
- lack-of-sterility
- contamination-risk
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lots: 06272022@6 BUD: 08/26/2022
- 07212022@3 BUD: 09/19/2022
- 07292022@11 BUD: 09/27/2022
- 08052022@7 BUD: 10/04/2022
- 08102022@5 BUD: 10/09/2022
- 08122022@14 BUD: 10/11/2022
- 08172022@7 BUD: 10/16/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27